ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Shaanxi Meibang Pharmaceutical Group Co's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 14.81%.
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Shaanxi Meibang Pharmaceutical Group Co's WACC % is 8.88%. Shaanxi Meibang Pharmaceutical Group Co's ROC % is 6.21% (calculated using TTM income statement data).
Shaanxi Meibang Pharmaceutical Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Shaanxi Meibang Pharmaceutical Group Co ROC % Related Terms
Shaanxi Meibang Pharmaceutical Group Co ROC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Meibang Pharmaceutical Group Co ROC % Chart
Shaanxi Meibang Pharmaceutical Group Co Annual Data
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a ROC % of 14.81% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors.
Is Shaanxi Meibang Pharmaceutical Group Co's ROC % too high?
Shaanxi Meibang Pharmaceutical Group Co's current ROC % is 14.81%. The Agriculture industry median ROC % is 5.48. Shaanxi Meibang Pharmaceutical Group Co's value of 14.81% is 170.5% above this industry median. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's ROC % compare to CTVA and CF?
Shaanxi Meibang Pharmaceutical Group Co's ROC % of 14.81% can be compared against companies in the Agriculture industry. The industry median ROC % is 5.48. Shaanxi Meibang Pharmaceutical Group Co's value of 14.81% is 170.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Agriculture company?
The median ROC % among Agriculture companies is 5.48, based on 256 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current ROC % of 14.81% is 170.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median ROC % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current ROC % is 14.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current ROC % is 14.81% and 170.5% above the Agriculture industry median of 5.48. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current ROC % is 14.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13.
GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:605033:
ROC %: 14.81%
GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
Industry Position: 170.5% above the Agriculture median
No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Meibang Pharmaceutical Group Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605033 has been successfully added to your 
